Delighted to see this published in Radiology: Cardiothoracic Imaging @rsnasky.bsky.social - important to continue to drive development in pleural imaging. Big thanks to all my coauthors and especially @kevingblyth.bsky.social
Full text link below to a review article just published in Current Pulmonary Reports on Non-Specific Pleuritis. A key topic for those interested in #mesothelioma evolution.
Well done to first author Mark Neilly and thanks to our co-author and pathology colleague, Craig Dick 👏
rdcu.be/d9Fgg
Great to be in beautiful Edinburgh for the National #Mesothelioma Education Day 2025 🏴
Dr Neil McGlinchey kicking off the meeting in fantastic setting at Royal College of Physicians
Looking forward to this tomorrow ⬇️
National #Mesothelioma Network Education Day
✅ New Management Guideline
🩻 New Staging (TNM 9)
📈 Review of Audit Performance (QPI)
Plus Trials, Interventional Pain, Pleural Nursing & Horizon scanning
…then, dinner with team 🎉🍷
Check out this interview with our #PREDICTMeso PI @kevingblyth.bsky.social discussing #mesothelioma; why it takes so long to develop, and what we at @predict-meso.bsky.social are doing to research and develop new treatments
#MesotheliomaResearch #MesoORIGINS #CancerResearch #EarlyDetection
A few mins of #Mesothelioma chat starts @1251 on BBC Scotland Lunchtime Live👇
Why does meso develop decades after exposure?
What are we doing in @predict-meso.bsky.social to develop new treatments?
@uofglasgow.bsky.social
@cruk-si.bsky.social
@cancerresearchuk.org
www.bbc.co.uk/sounds/play/...
Looking forward to talking #mesothelioma on BBC Scotland Lunchtime Live in a few minutes!
There are now 24 step-by-step guides, explaining how to create these ⬇️ data visualizations with R/ggplot2 - I hope this is a useful resource. Find them all here: joachimgoedhart.github.io/DataViz-prot...
Article in @heraldscotland.bsky.social this week highlights a sad #mesothelioma story & ongoing research in PREDICT-Meso, IAMMED, Meso-SCAPE & excellent Hansen lab
@predict-meso.bsky.social
@djmurphylab2.bsky.social
@cruk-si.bsky.social
www.heraldscotland.com/news/2477596...
It was great to be part of the BTOG/MesoUK Essential Update meeting this week
Topics included diagnostics, new Rx, CNS roles, legal, pleural
Nice to see 2 current PhD students presenting
🏴 Meso Network (Matt)
🧬 PREDICT-Meso (Mark)
@btog.bsky.social
@mesouk.bsky.social
@uofglasgow.bsky.social
Very proud of Jenny Ferguson - PhD viva passed today! 🎉🥂
Her thesis on stratification of #respiratory disease covered
🫁 STRATIFY trial of #pleural staging in Lung Ca
🔬Predictive Markers in #MPE
🦠 Immune markers of severe #COVID19
🙏 R Bhatnagar, C Church & L Richmond!
@uofglasgow.bsky.social
Graphic featuring logos of NHS and Research for the Future, accompanied by an image of a young woman in a wheelchair using a laptop for an online meeting. This visual illustrates the PREDICT-MESO project, which aims to establish a Patient and Public Involvement and Engagement (PPIE) group. The group will provide valuable input at all stages of mesothelioma research.
🟡 Recruiting now – PREDICT-Meso PPI Group
People affected my mesothelioma to join a new PPI group to advise on all stages of mesothelioma research.
Message us or visit our website… www.researchforthefuture.org/studies/predict-meso
New paper from our group on body composition changes in #mesothelioma during chemo ⬇️
💪 61.5% patients lost muscle
🧈 60.4% patients lost fat
🫁 Extreme thoracic muscle loss & total fat loss independently prognostic
Funded by Asthma+Lung UK
www.sciencedirect.com/science/arti...
Kevin Blyth: management of mesothelioma effusion
🔹IPC vs pleurodesis = equivalent efficacy
For pleurodesis:
🔹 Talc = most effective agent
🔹 Big drain no better than smaller ones
🔹 NSAIDs fine for analgesia (won’t limit pleurodesis)
🔹 Talc slurry as good as poudrage
@dean_fennell: 2L mesothelioma options
👉 (small) subset of non-epithelioid pts do very well with Vin
🟢 Gem+Ramucirumab = ⬆️ PFS
❓ Gem maintenance = ⬆️ PFS, but a bit forgotten
🟢 Platinum rechallenge RR 50%
❓Activity in immuno rechallenge, RR up to 50%
Improve your mesothelioma service by forming a network: the 🏴 experience by Matthew Tate
🟢 ⬆️ data completeness
🟢 ⬇️ non-biopsy cases
🟢 ⬆️ OS in non-epithelioid
🔺 OS benefit not solely due to arrival of immunotherapy
@btog.bsky.social
@mesouk.bsky.social
PREDICT-Meso:
🧐 How does inflammation evolve into malignancy?
🧐 Can we diagnose mesothelioma at pre-malignant stage?
👉 80 institutions, 16 countries
👉 x5 work streams
Fantastic, ambitious, international, multi-faceted project
@btog.bsky.social
@mesouk.bsky.social
Matthew Tate presenting outcomes from the Scottish #Mesothelioma Network
⬆️ Overall Survival in Non-Epi cases
⬆️ Use of Immunotherapy
⬆️ OS in Non-Epi cases not receiving IO
Mesothelioma networks should be developed across the UK
Was that a collective sigh of relief, I heard?
On-call week for me at #QEUH Lots of Flu A! 🦠😷 Felt like every other patient today.
Will be interested to see if the upward trend in last weeks numbers continues publichealthscotland.scot/publications...
24 windows of an advent calendar each with a Christmas themed picture eg snowflakes, a cute fox in a scarf, mittens, and a bobble hat . The title is Merry Respmas Advent Calendar
Can you believe it, it’s almost December! This year we’re excited to bring you a #RespMas advent calendar! Every day we’ll open a window to reveal a paper worth reading! By Christmas we’ll all be on top of our Respiratory game! #medsky #pulmsky #lungsky #RespEd #RespIsBest
Hey Sanjay! Nice to see you on here !
This is why we are all in this field…to see, and one day to be able to produce work like this.
Patho-DBiT-seq
www.cell.com/cell/fulltex...
Heading home after a fantastic #BTSWinter2024 Leaving energised and grateful for friends and the opportunity to talk #mesothelioma in the Plenary Scientific Symposium. Also excited for 2025 under our new BTS President!
This morning I presented results of the STRATIFY multi-centre trial of staging thoracoscopy for minimal pleural effusion in lung cancer. The prevalence of occult pleural mets was only 14%, thoracoscopy was safe & altered treatment plans. Paper coming soon! #BTSWinter2024
x.com/UKPleura/sta...
I'm very grateful to Asthma & Lung UK for the early support they provided to our now international #mesothelioma research program. Pump-priming is such an impactful strategy for grant-awarding charities x.com/IanJarroldAL...
Day 2 of #WinterBTS2024 started with a sunny walk in followed by presentation of STRATIFY results (pleural staging of Mini-PE). Next up is #mesothelioma presentation at Plenary Scientific Symposium 😬
Sorry to have missed it! Too many overlapping sessions (a good sign I guess!)
This is starting now at #BTSwinter2024 in Windsor on 5th floor!
